China Medicine Corporation

CHME · OTC
Analyze with AI
12/31/2009
12/31/2008
12/31/2007
12/31/2006
Operating Activities
Net Income$1,402$9,126$6,875$4,788
Dep. & Amort.$1,012$421$784$162
Deferred Tax$21$46$0$0
Stock-Based Comp.$131$88$0$0
Change in WC$7,114-$5,353-$10,073-$7,956
Other Non-Cash$7,278-$118$103$787
Operating Cash Flow$16,959$4,209-$2,310-$2,218
Investing Activities
PP&E Inv.-$3,674-$2,666-$390-$826
Net Acquisitions-$8,000$0$0$0
Inv. Purchases$0-$5,197$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1,862$0$0$0
Investing Cash Flow-$13,536-$7,863-$390-$826
Financing Activities
Debt Repay.-$4,040$0$0-$94
Stock Issued$0$0$7,830$3,783
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,709$363$0-$200
Financing Cash Flow-$5,749$363$7,830$3,489
Forex Effect$6$316$266-$165
Net Chg. in Cash-$2,320-$2,976$5,396$280
Supplemental Information
Beg. Cash$2,792$5,768$371$92
End Cash$472$2,792$5,768$371
Free Cash Flow$13,286$1,543-$2,700-$3,045